Patient Pathfinder: Clinical Trials
Clinical Trials for Myelodysplastic Syndrome
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myelodysplastic Syndrome (MDS), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 166 active Myelodysplastic Syndrome trials
PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation
Study Type: Interventional Phase 1
NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS
Study Type: Interventional Phase 1
Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies
Study Type: Interventional
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
Study Type: Interventional Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
Study Type: Interventional Phase 2
Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
Study Type: Interventional Phase 1
CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
Study Type: Interventional Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
Study Type: Interventional Phase 1
There are 166 active Myelodysplastic Syndrome trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now